Metronidazole vaginal gel and surgical site infection

Evaluation of the effect of metronidazole vaginal gel in reducing surgical site infection in patients undergoing elective hysterectomy

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200217046523N9

Enrollment

100

Registered

2021-01-15

Start date

2021-01-28

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical site infection. Infection of obstetric surgical wound

Interventions

Intervention 1: Intervention group: Patients in this group will be treated with metronidazole vaginal cream daily for three nights before surgery. Then the patients will be operated on and 2 weeks and

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Candidate for elective hysterectomy Obtaining written consent

Exclusion criteria

Exclusion criteria: Hysterectomy followed by cesarean section Hysterectomy following a normal delivery Emergency hysterectomies Patients who have received broad-spectrum antibiotics before surgery Patient dissatisfaction Infection of the patient with vaginitis with cervicitis in the preoperative period

Design outcomes

Primary

Measure	Time frame
Infection. Timepoint: Two weeks and six weeks after surgery. Method of measurement: Examination and patient history.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFahime Sabet

Esfahan University of Medical Sciences

Dr.fsabet@yahoo.com+98 31 3668 0042

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026